Filing Details

Accession Number:
0000904454-22-000335
Form Type:
13D Filing
Publication Date:
2022-05-19 20:00:00
Filed By:
Alpinvest Us Holdings, Llc
Company:
Carlyle Credit Solutions Inc.
Filing Date:
2022-05-20
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
AlpInvest Indigo I CI-A 0 1,064,509 0 1,064,509 1,064,509 1.87%
AlpInvest Indigo SCF I CI GP 0 1,064,509 0 1,064,509 1,064,509 1.87%
AlpInvest US Holdings 0 1,064,509 0 1,064,509 1,064,509 1.87%
Filing

 

United States
Securities and Exchange Commission
Washington, D.C. 20549
 

SCHEDULE 13D
(Rule 13d-101)

Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and
Amendments Thereto Filed Pursuant to § 240.13d-2(a)

Under the Securities Exchange Act of 1934
(Amendment No. )*
 

Carlyle Credit Solutions, Inc.
(Name of Issuer)

Common Stock, par value $0.01 per share
(Title of Class of Securities)

None
(CUSIP Number)

Michael Thorne, Esq.
AlpInvest US Holdings, LLC
One Vanderbilt Ave, Suite 3400
New York, N.Y. 10171
Telephone: (212) 332-6240
 
 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

May 3, 2022
(Date of Event Which Requires Filing of This Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [   ]
 








CUSIP Number:  None


1
 
NAMES OF REPORTING PERSONS

AlpInvest Indigo I CI-A, L.P.

2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [   ] (b) [X]

3
 
SEC USE ONLY


4
 
SOURCE OF FUNDS (SEE INSTRUCTIONS)

OO

5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
[   ]

6
 
CITIZENSHIP OF PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
 
SOLE VOTING POWER

0

8
 
SHARED VOTING POWER

1,064,509.249

9
 
SOLE DISPOSITIVE POWER

0

10
 
SHARED DISPOSITIVE POWER

1,064,509.249

11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,064,509.249

12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[   ]

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.87%(1)

14
 
TYPE OF REPORTING PERSON

OO (Delaware limited partnership)









CUSIP Number:  None


1
 
NAMES OF REPORTING PERSONS

AlpInvest Indigo SCF I CI GP, L.P.

2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [   ] (b) [X]

3
 
SEC USE ONLY


4
 
SOURCE OF FUNDS (SEE INSTRUCTIONS)

WC

5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
[   ]

6
 
CITIZENSHIP OF PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
 
SOLE VOTING POWER

0

8
 
SHARED VOTING POWER

1,064,509.249

9
 
SOLE DISPOSITIVE POWER

0

10
 
SHARED DISPOSITIVE POWER

1,064,509.249

11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,064,509.249

12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[   ]

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.87%(1)

14
 
TYPE OF REPORTING PERSON

OO (Delaware limited partnership)









CUSIP Number:  None


1
 
NAMES OF REPORTING PERSONS
AlpInvest US Holdings, LLC

2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [   ] (b) [X]

3
 
SEC USE ONLY


4
 
SOURCE OF FUNDS (SEE INSTRUCTIONS)

OO

5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
[   ]

6
 
CITIZENSHIP OF PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
7
 
SOLE VOTING POWER

0

8
 
SHARED VOTING POWER

1,064,509.249

9
 
SOLE DISPOSITIVE POWER

0

10
 
SHARED DISPOSITIVE POWER

1,064,509.249

11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,064,509.249

12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[   ]

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

1.87%(1)

14
 
TYPE OF REPORTING PERSON

OO (Delaware limited liability company)


_________
(1) All percentage ownership of shares of Common Stock of Carlyle Credit Solutions, Inc., par value $0.01 per share (the “Common Stock”), by Reporting Persons presented in this Schedule 13D is based on an aggregate of 57,005,057 shares issued and outstanding as of the date of this filing.








CUSIP Number:  None


Item 1.
Security and Issuer.
This statement on Schedule 13D (the “Schedule 13D”) relates to the shares of Common Stock of Carlyle Credit Solutions, Inc., a Maryland corporation (the “Issuer”) whose principal executive offices are located at One Vanderbilt Avenue, Suite 3400, New York, New York 10017.

Item 2.
Identity and Background.
The Schedule 13D is being filed by the following persons (each a “Reporting Person” and, collectively, the “Reporting Persons”):
1.
AlpInvest Indigo I CI-A, L.P. (the “AlpInvest LP”),
2.
AlpInvest Indigo SCF I CI GP, L.P. (the “AlpInvest GP”) and
3.
AlpInvest US Holdings, LLC (the “AlpInvest Manager”).
Each of the Reporting Persons is organized in the state of Delaware. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is attached hereto as Exhibit 1.
The AlpInvest GP serves as the general partner of the AlpInvest LP and the AlpInvest Manager serves as the manager of the AlpInvest GP.
The principal business of each of the Reporting Persons is to facilitate the investments of underlying accounts. The address of the principal business and principal office of each of the Reporting Persons is c/o AlpInvest US Holdings, LLC, One Vanderbilt Avenue, Suite 3400, New York, New York 10171.
The AlpInvest LP is a limited partner of CDL Tender Fund 2022-1, L.P., a Delaware limited partnership (the “Purchaser”), which was formed solely for the purpose of completing a tender offer to purchase up to $100,000,000 in aggregate amount of shares of the Common Stock at a purchase price equal to $20.13 per share (the “Offer”), which expired at 11:59 p.m., New York City Time, on May 3, 2022 (the “Expiration Date”), and otherwise acquiring shares of Common Stock. The Purchaser had not conducted any business prior to those related to the structuring and negotiation of the Offer. Until shortly prior to the time of commencement of the Offer, the Purchaser had no significant assets or liabilities or engaged in activities other than those incidental to their formation, capitalization and the consummation of the transactions contemplated by the Offer.
The Purchaser is wholly owned by its limited partners: (1) Carlyle Global Credit Investment Management L.L.C. (“CGCIM”), a Delaware limited liability company, (2) the AlpInvest LP and (3) Cliffwater Corporate Lending Fund (“CCLF” and, together with CGCIM and the AlpInvest LP, the “Limited Partners”), a Delaware statutory trust. Voting and investment control over the securities directly held by the Purchaser is exercised by the Purchaser’s limited partners and CDL Tender Fund 2022-1 GP, L.L.C., acting as general partner of the Purchaser (the “General Partner”); the Purchaser has no voting or investment control over such securities.
The name, business address, citizenship, present principal occupation and employment history of each of the officers of the controlling persons of the AlpInvest LP, the AlpInvest GP and the AlpInvest Manager, respectively, are set forth in Schedule A to this Schedule 13D (such officers, collectively, the “Related Persons”).
During the last five years, none of the Reporting Persons or Related Persons (i) has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 3.
Source and Amount of Funds or Other Consideration.
On May 3, 2022, the Purchaser purchased 4,967,709.926 shares of Common Stock at $20.13 per share in connection with the Offer.
The source of funds required for the Purchaser to purchase the shares of Common Stock in connection with the Offer was from working capital from capital contributions from the Limited Partners, approximately $28.6 million of which was contributed by CGCIM, $50 million of which was contributed by the CCLF and approximately $21.4 million of which was contributed by the AlpInvest LP. The AlpInvest LP’s capital contribution was from unfunded commitments of its investors.








CUSIP Number:  None


Item 4.
Purpose of Transaction.
The information set forth in or incorporated by reference in Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4.

The Reporting Persons acquired the shares of Common Stock for investment purposes and they intend to review their investments in the Issuer on a continuing basis. Any actions the Reporting Persons might undertake may be made at any time and from time to time without prior notice and will be dependent upon the terms set forth in the Limited Partnership Agreement (as defined below) and the Reporting Persons’ review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer’s business, financial condition, operations and prospects; price levels of the Issuer’s securities; general market, industry and economic conditions; the relative attractiveness of alternative business and investment opportunities; and other future developments.
The purpose of the Offer was for the Limited Partners, indirectly through the Purchaser, to make a significant investment in the Issuer. In addition, the Offer was made in furtherance of the Issuer’s plan to provide a source of liquidity to the Issuer’s stockholders through a one-time tender offer for shares of Common Stock funded either by the Issuer, one of the Issuer’s affiliates, or a third party with the Issuer’s support, as disclosed in the Issuer’s Definitive Proxy Statement on Schedule 14A filed with the SEC on November 23, 2021 (the “Special Meeting Proxy Statement”). Under the Limited Partnership Agreement, the Limited Partners may, at the discretion of one or more Limited Partners, acquire additional shares of Common Stock after the Expiration Date by making additional capital contributions to the Purchaser (subject to acceptance by the General Partner), which the Purchaser will use to acquire additional shares of Common Stock in respect of the relevant Limited Partner(s), or by subscribing directly for shares of Common Stock in connection with the Issuer’s new continuous private offering of shares of Common Stock to existing stockholders and new investors in reliance on Regulation D or another exemption from the registration requirements of the Securities Act of 1933, as amended.

The Reporting Persons do not have any knowledge of any plans or proposals that relate to or would result in: (a) the acquisition by any person of additional shares of Common Stock or the disposition of shares of Common Stock (except for periodic discretionary solicitations of tender offers by the Issuer as disclosed in the Special Meeting Proxy Statement); (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer; (c) a sale or transfer of a material amount of assets of the Issuer; (d) any change in the identity of the investment adviser to the Issuer or the composition of the Board, or in the management of the Issuer including, but not limited to, any plans or proposals to change the number or the term of the members of the Board, to change any material term of the investment advisory arrangements with CGCIM; (e) any material change in the present distribution policy or capitalization of the Issuer; (f) any other material change in the Issuer’s structure or business; (g) any changes in the Issuer’s Articles of Amendment and Restatement or Bylaws or other actions that may impede the acquisition of control of the Issuer by any person; or (h) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

Because shares of Common Stock are not traded in any market or on any national securities exchange, subsection (h) of Item 4 of Schedule 13D is not applicable.

Notwithstanding the foregoing in this Item 4, depending on the factors discussed herein, the Reporting Persons may change their purpose or formulate different plans or proposals with respect thereto at any time. The Reporting Persons may communicate with the Issuer’s board of directors (the “Board”), members of the Issuer’s management or other security-holders of the Issuer, or other third parties from time to time, regarding the matters described in this Item 4 or otherwise take actions with respect to such matters, and such discussions and actions may be preliminary and exploratory in nature, and not rise to the level of a plan or proposal.








CUSIP Number:  None


Item 5.
Interest in Securities of the Issuer.
The information set forth in or incorporated by reference in Item 2, Item 3 and Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 5.
(a) – (b)
The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares and percentage of Common Stock beneficially owned by each of the Reporting Persons, as well as the number of shares of Common Stock as to which each Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition of, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 57,005,057 shares of Common Stock outstanding.

Reporting Person
 
Amount beneficially owned
 
Percent of class
 
Sole power to vote or to direct the vote
 
Shared power to vote or direct the vote
 
Sole power to dispose or to direct the disposition
 
Shared power to dispose or to direct the disposition
AlpInvest Indigo I CI-A, L.P.
 
1,064,509.249 (1)
 
1.87%
 
0
 
1,064,509.249
 
0
 
1,064,509.249
AlpInvest Indigo SCF I CI GP, L.P.
 
1,064,509.249 (1)
 
1.87%
 
0
 
1,064,509.249
 
0
 
1,064,509.249
AlpInvest US Holdings, LLC
 
1,064,509.249 (1)
 
1.87%
 
0
 
1,064,509.249
 
0
 
1,064,509.249
_______
(1)
The AlpInvest LP is party to the Limited Partnership Agreement (as defined below). By virtue of the Limited Partnership Agreement, the AlpInvest LP may be deemed to (1) share voting and investment control over the equity securities held by the Purchaser, which consists solely of shares of Common Stock owned by the Limited Partners that were acquired in connection with the Offer, and (2) have formed a “group” with the CCLF, CGIM and the General Partner for purposes of Section 13(d)(3) of the Exchange Act. Collectively, the “group” may be deemed to beneficially own an aggregate of 5,837,714.251 shares of Common Stock (which includes 870,004.325 shares of Common Stock beneficially owned by CGCIM prior to the Expiration Date), which represents approximately 10.24% of the Issuer’s outstanding shares of Common Stock as of the date of filing of this Schedule 13D. Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that any Reporting Person is a member of any such group. 
Each Reporting Person expressly disclaims beneficial ownership of any shares of Common Stock beneficially owned or deemed beneficially owned by CCLF, CGIM, the General Partner, the other Reporting Persons and/or the Related Persons except to the extent of such Reporting Person’s interest therein by virtue of the terms of the Limited Partnership Agreement.
Each of the Reporting Persons is filing this Schedule 13D out of an abundance of caution in connection with the acquisition by the AlpInvest LP, indirectly through the Purchaser, of shares of Common Stock as a result of the Offer.  By virtue of the relationship among the Reporting Persons described in Item 2, each such Reporting Person may be deemed to share the power to vote or direct the vote and to share the power to dispose of or direct the disposition of the 1,064,509.249 shares of Common Stock as set forth in rows 7, 8, 9, 10, 11 and 13 of each of the cover pages of this Schedule 13D.

(c)
Except as described in this Schedule 13D, during the past 60 days none of the Reporting Persons or Related Persons has effected any transactions in the Common Stock.
(d)
None.
(e)
Not applicable.








CUSIP Number:  None

Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
The information set forth or incorporated in Item 3 and Item 4 is hereby incorporated by reference in its entirety into this Item 6.

The Limited Partnership Agreement. On April 4, 2022, the General Partner, each Limited Partner and Carlyle SLP LTD. (solely to reflect its withdrawal as initial limited partner of the Purchaser) entered into the Limited Partnership Agreement, in connection with which CGCIM, CCLF and the AlpInvest LP contributed $28.6 million, $50 million and $21.4 million in cash, respectively, to the Purchaser in order for the Purchaser to conduct the Offer for up to $100,000,000 in aggregate amount of shares of Common Stock. Pursuant to the terms of the Limited Partnership Agreement, the Purchaser will not hold any investment other than the shares of Common Stock and cash.
As permitted under the Limited Partnership Agreement, the General Partner has delegated certain investment management obligations with respect to the Purchaser to CGCIM, which serves as investment adviser to the Purchaser pursuant to the terms of an investment advisory agreement between the Purchaser and CGCIM, under which the Purchaser will not be charged with any investment advisory fees. The General Partner is not relieved of any of its obligations under the Limited Partnership Agreement as a result of such delegation.
Under the terms of the Limited Partnership Agreement, among other things:

In the event that there is a subsequent special tender offer for shares of Common Stock (excluding, for the avoidance of doubt, any tender offer pursuant to the Issuer’s anticipated quarterly liquidity program), each Limited Partner will be given a reasonable opportunity to participate.
The General Partner may, in its sole discretion, admit additional limited partners to the Purchaser in accordance with the terms of the Limited Partnership Agreement.
The Purchaser may, at the request of its limited partners and upon receiving a capital commitment from any such limited partner, commit to purchase additional shares of Common Stock pursuant to subscription agreements between the Purchaser and the Issuer, which must be substantially similar in all material respects to each other subscription agreement providing for the admission of institutional investors to the Issuer.
The General Partner will distribute to the Purchaser’s limited partners any amounts/proceeds received on shares of Common Stock held by the Purchaser (including with respect to dividends/distributions received from the Issuer) as soon as practicable after the date such amounts/proceeds are received by the Purchaser, but in no event later than 30 calendar days following receipt of such amounts/proceeds. All such distributions will be paid to the Purchaser’s limited partners based on the limited partners’ percentage ownership of the Purchaser’s interests.
In addition to general powers customarily granted to general partners of a limited partnership, among other things, the General Partner is permitted to take all actions to cause the Purchaser to invest in shares of Common Stock. The General Partner, however, has no right to cause the Purchaser to borrow or otherwise incur indebtedness and is not permitted to hypothecate, charge, mortgage, assign, transfer, make a collateral assignment or pledge or grant a comparable security interest to a lender or other credit party of the Purchaser of the assets of the Purchaser or any capital commitments from limited partners or rights to call or receive capital contributions in connection with such capital commitments.
Whenever any consent or vote of the holders of shares of Common Stock is solicited, the General Partner will solicit the consent of its limited partners in writing, and the General Partner will cause the Purchaser to provide its consent or vote to the Issuer with respect to the shares of Common Stock then held by the Purchaser in the same ratio as the limited partner’s consent under the terms of the Limited Partnership Agreement (such ratio determined in respect of the then-current portion of shares of Common Stock that are attributable to the respective limited partners of the Purchaser). With the consent of the relevant limited partner, the General Partner will be permitted to elect, under and subject to the provisions of the Issuer’s charter, to hold all or any fraction of the Purchaser’s interest in the shares of Common Stock in respect of such limited partner as a non-voting interest. The pass-through voting provisions of the Limited Partnership Agreement must conform to the requirements of Section 12(d)(1)(E) of the Investment Company Act of 1940, as amended (the “1940 Act”).
The Purchaser’s limited partners may not transfer their interests in (including any right to receive distributions or allocations in respect of such interests), or capital commitments to, the Purchaser, whether voluntarily, involuntarily, by merger, by operation of law or otherwise in whole or in part to any person without the prior written consent of the General Partner, which will not be unreasonably withheld. However, the General Partner will not withhold its consent to any such transfer if the proposed transferee is an affiliate of such limited partner, subject to certain suitability requirements and required representations set forth in the Limited Partnership Agreement.
On or after the two-year anniversary of the Expiration Date, upon the written request of any Limited Partner, the General Partner will use commercially reasonable efforts to help facilitate a transfer by such Limited Partner of all or any portion of such shares of common stock held by the Purchaser that are attributable to such Limited Partner to another entity or individual, subject to certain suitability requirements, representations and other requirements set forth in the Limited Partnership Agreement.
Starting on the date of the Purchaser’s acquisition of shares of Common Stock pursuant to the Offer, through the date that falls on the 18-month anniversary thereof (the “Lockup Period”), the Purchaser, as a stockholder of the issuer, will not be permitted to tender any of its shares of Common Stock in connection with any issuer tender offer for shares of Common Stock conducted by the Issuer. Following the Lockup Period, the Purchaser will participate in the Issuer’s issuer tender offers at the discretion, and in accordance with the instruction, of the Purchaser’s limited partners; however, in the event that the Issuer conducts one or more tender offers as required by Section 61(a)(2)(D)(ii) of the 1940 Act, in connection with a change in the Issuer’s asset coverage requirements, neither the Purchaser nor any of its limited partners in its individual capacity will participate in such tender offer(s).









CUSIP Number:  None



The Purchaser will at no time hold 25% or more of the then-outstanding shares of Common Stock, and the General Partner will use its commercially reasonable efforts to reduce the number of shares then held by the Purchaser to the extent it determines that there is a reasonable possibility that it may exceed such threshold within 30 days. In addition, for so long as the Purchaser holds 5% or more of the then-outstanding shares of Common Stock, the General Partner will take such steps, as will its affiliates, including the Issuer’s investment adviser, to take such steps, in each case as may be reasonably necessary to ensure that no transaction occurs in violation of Section 57 of the 1940 Act to which a limited partner of the Purchaser may be a party; provided that, to the extent any limited partner of the Purchaser and the Issuer may be parties to a proposed transaction that would otherwise violate Section 57(d) of the 1940 Act, the General Partner and its affiliates will use commercially reasonable efforts to cause the Board to approve the participation of such limited partner in such transaction in the manner provided for under Section 57(f) of the 1940 Act.
The Purchaser will indemnify and hold harmless the General Partner and certain of its related parties and affiliates (including their respective members, officers, directors, employees, operating executives, managers, consultants, advisors, senior advisors, stockholders, shareholders, partners (other than limited partners of the Purchaser in their capacity as such), agents, and any other person who serves at the request of the General Partner on behalf of the Purchaser as an officer, director, partner, member, consultant, senior advisor, operating executive or employee of or advisor to any other entity, each an “Indemnified Party”) from and against any and all claims, liabilities, damages, losses, costs and expenses (including legal fees and amounts paid in satisfaction of judgments, in compromises and settlements, as fines and penalties and legal or other costs and reasonable expenses of investigating or defending against any claim or alleged claim) of any nature whatsoever, known or unknown, liquidated or unliquidated, whether or not in connection with proceedings by or in the right of the Purchaser or any of its partners, that are incurred by any Indemnified Party and arise out of or in connection with the affairs of the Purchaser, the Issuer or any activities undertaken in connection with the Purchaser or the Issuer, including acting as a director or the equivalent of any entity in or through which an investment in shares of Common Stock is made, directly or indirectly, or the performance by such Indemnified Party of any of the General Partner’s responsibilities under the Limited Partnership Agreement or otherwise in connection with the matters contemplated in the Limited Partnership Agreement, subject to certain exceptions, limitations and other terms set forth in the Limited Partnership Agreement, including that no Indemnified Party will be entitled to such indemnification to the extent that such Indemnified Party’s conduct constituted Disabling Conduct (as defined in the Limited Partnership Agreement).

The term of the Purchaser will generally expire on the date on which the Issuer dissolves in accordance with its governing documents, if at all, subject to the terms of the Limited Partnership Agreement. However, the General Partner may, upon not less than 30 days prior written notice to the limited partners of the Purchaser, distribute all of the shares of Common Stock then held by the Purchaser on a pro rata basis in kind to the limited partners, provided that such a distribution would not cause a violation of any applicable law on the part of the Purchaser or any of its limited partners, including under the 1940 Act.


The Tender Offer Subscription Agreement. On April 4, 2022, the Issuer accepted an executed subscription agreement from the Purchaser (the “Tender Offer Subscription Agreement”), pursuant to which all shares of Common Stock purchased by the Purchaser in the Offer are subject to rights and obligations substantially similar to those held by existing stockholders of the Issuer but without any obligation to purchase additional shares.

The above summaries of the material terms of the Limited Partnership Agreement and the Tender Offer Subscription Agreement are qualified by reference to the Limited Partnership Agreement and the Tender Offer Subscription Agreement, which are filed as Exhibits 2 and 3 hereto, respectively, and are incorporated herein by reference.

Item 7.
Materials to be Filed as Exhibits

Exhibit
Number
 
Description
   
1
 
Joint Filing Agreement.
   
2
 
Amended and Restated Limited Partnership Agreement of CDL Tender Fund 2022-1, L.P., dated as of April 4, 2022 (incorporated by reference to Exhibit (d)(1) to the Tender Offer Statement on Schedule TO filed by the Purchaser on April 5, 2022 (the “Schedule TO”)).
   
3
 
Form of Subscription Agreement (incorporated by reference to Exhibit (d)(3) to the Schedule TO).
     








CUSIP Number:  None


SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: May 20, 2022

 
ALPINVEST INDIGO I CI-A, L.P.
 
 
 
By:
AlpInvest Indigo SCF I CI GP, L.P., its general partner
 
 
By:
AlpInvest US Holdings, LLC, its manager
 
       
 
By:
/s/ Michael Thorne
 
 
Name:
Michael Thorne
 
 
Title:
Chief Legal Officer
 
       
 
By:
/s/ Cameron Fairall
 
 
Name:
Cameron Fairall
 
 
Title:
Chief Compliance Officer
 
       
       
 
ALPINVEST INDIGO SCF I CI GP, L.P.
 
 
 
By:
AlpInvest US Holdings, LLC, its manager
 
       
 
By:
/s/ Michael Thorne
 
 
Name:
Michael Thorne
 
 
Title:
Chief Legal Officer
 
       
 
By:
/s/ Cameron Fairall
 
 
Name:
Cameron Fairall
 
 
Title:
Chief Compliance Officer
 
       
       
 
ALPINVEST US HOLDINGS, LLC
 
 
 
By:
/s/ Michael Thorne
 
 
Name:
Michael Thorne
 
 
Title:
Chief Legal Officer
 
       
 
By:
/s/ Cameron Fairall
 
 
Name:
Cameron Fairall
 
 
Title:
Chief Compliance Officer
 
       
       








CUSIP Number:  None


SCHEDULE A

Controlling Persons of
AlpInvest Indigo I CI-A, L.P., AlpInvest Indigo SCF I CI GP, L.P. and AlpInvest US Holdings, LLC

AlpInvest Indigo SCF I CI GP, L.P., a Delaware limited partnership, serves as the general partner to AlpInvest Indigo I CI-A, L.P.  AlpInvest Indigo SCF I CI GP, L.P. is managed by AlpInvest US Holdings, LLC, a Delaware limited liability company.  The business address of AlpInvest US Holdings, LLC is One Vanderbilt Ave, Suite 3400, New York, NY 10017 and the phone number at such business address is (646) 735-4293.  AlpInvest US Holdings, LLC is an affiliated sub-adviser of AlpInvest Partners B.V., a U.S. registered investment adviser whose address is Jachthavenweg 118, 1081 KJ, Amsterdam, the Netherlands.

Directors and Executive Officers of AlpInvest Partners B.V. and Affiliates

The name, position, business address, citizenship, present principal occupation or employment and material occupations, positions, offices or employment for the past five years of each of the directors and executive officers of AlpInvest Partners B.V. and affiliates are set forth below. Each of the below-listed individuals has been at AlpInvest Partners B.V. or an affiliate for more than five years.

         
Name and Position
 
Business Address and Citizenship
 
Present Principal Occupation or Employment and
Employment History
Geertruida Bagjin, Director
 
Jachthavenweg 118, 1081 KJ, Amsterdam, the Netherlands
Citizenship: Netherlands
 
 
Director of AlpInvest Partners B.V.
 
Erica Herberg, Director
 
 One Vanderbilt Ave, Suite 3400, New York, NY 10017
Citizenship: United States
 
 
Director of AlpInvest Partners B.V.
Wouter Moerel, Director
 
Jachthavenweg 118, 1081 KJ, Amsterdam, the Netherlands
Citizenship: Netherlands
 
 
Director of AlpInvest Partners B.V.
Cameron Fairall,
Chief Compliance Officer
 
One Vanderbilt Ave, Suite 3400, New York, NY 10017
Citizenship: United States
 
 
Chief Compliance Officer of AlpInvest US Holdings, LLC
Michael Steven Thorne,
Chief Legal Officer
 
One Vanderbilt Ave, Suite 3400, New York, NY 10017
Citizenship: United States
 
 
Chief Legal Officer of AlpInvest US Holdings, LLC








CUSIP Number:  None


Exhibit 1

Joint Filing Agreement

In accordance with the requirements of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and subject to the limitations set forth therein, the parties set forth below agree to jointly file the Schedule 13D to which this joint filing agreement is attached, and any subsequent amendments thereto, and have duly executed this joint filing agreement as of the date set forth below.

Date:  May 20, 2022

 
ALPINVEST INDIGO I CI-A, L.P.
 
 
 
By:
AlpInvest Indigo SCF I CI GP, L.P., its general partner
 
 
By:
AlpInvest US Holdings, LLC, its manager
 
       
 
By:
/s/ Michael Thorne
 
 
Name:
Michael Thorne
 
 
Title:
Chief Legal Officer
 
       
 
By:
/s/ Cameron Fairall
 
 
Name:
Cameron Fairall
 
 
Title:
Chief Compliance Officer
 
       
       
 
ALPINVEST INDIGO SCF I CI GP, L.P.
 
 
 
By:
AlpInvest US Holdings, LLC, its manager
 
       
 
By:
/s/ Michael Thorne
 
 
Name:
Michael Thorne
 
 
Title:
Chief Legal Officer
 
       
 
By:
/s/ Cameron Fairall
 
 
Name:
Cameron Fairall
 
 
Title:
Chief Compliance Officer
 
       
       
 
ALPINVEST US HOLDINGS, LLC
 
 
 
By:
/s/ Michael Thorne
 
 
Name:
Michael Thorne
 
 
Title:
Chief Legal Officer
 
       
 
By:
/s/ Cameron Fairall
 
 
Name:
Cameron Fairall
 
 
Title:
Chief Compliance Officer
 
       
       








12